
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy has demonstrated a positive trend in commercial pricing, which increased sequentially by 2.2%, indicating a stable demand for its services. Additionally, the company's Industrial Injury Prevention (IIP) revenue surged by 22.2% overall and 18.4% when excluding merger and acquisition contributions, reflecting robust growth in its operational segments. Furthermore, the recently acquired Metro business has shown a significant improvement in its net rate, rising from approximately $101 to $107.50, suggesting effective integration and value generation from acquisitions.
Bears say
US Physical Therapy has experienced a persistent decline in a key financial metric, decreasing 0.6% to $83.95 over the past year. The company continues to face significant reimbursement cuts, accumulating to a $20 million detriment to profitability over the last five years, which raises concerns about the sustainability of its revenue streams. Additionally, the reported clinic and other expenses increased to 20.2% of revenue, slightly surpassing the estimated 20.1%, indicating potential challenges in cost management that could further impact financial performance.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares